Preventive or therapeutic agent for age-related macular degeneration
a technology of age-related macular degeneration and therapeutic agent, which is applied in the direction of sense disorder, organic active ingredients, drug compositions, etc., can solve the problem of weakened barrier between the retina and the blood vessels, and achieve the effect of not expensive cos
Active Publication Date: 2017-11-23
JUNTENDO EDUCATIONAL FOUND
View PDF1 Cites 1 Cited by
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Benefits of technology
The patented method uses a special type of medicine called anti-AMD that works differently from regular drugs like beta blockers. This makes it less expensive compared to other treatments.
Problems solved by technology
This patent describes how age related changes can cause various types of ocular diseases including AMD. It suggests that there may also be other factors involved in this process, which could lead to further complications or even worse outcomes. These factors include genetics, environmental factors, and lifestyle factors.
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View moreImage
Smart Image Click on the blue labels to locate them in the text.
Smart ImageViewing Examples
Examples
Experimental program
Comparison scheme
Effect test
Login to view more PUM
| Property | Measurement | Unit |
|---|---|---|
| Electrical conductance | aaaaa | aaaaa |
| Electrical conductance | aaaaa | aaaaa |
Login to view more
Abstract
To provide a new preventive or therapeutic agent for age-related macular degeneration.
The present invention relates to a preventive or therapeutic agent for age-related macular degeneration containing a BLT1 antagonist or a LTB4 biosynthesis inhibitor as an active ingredient. The administration form of the preventive or therapeutic agent for age-related macular degeneration of the present invention includes eye drops, injections, oral agents (tablets, granules, dispersions, capsules), ointments, and creams. The form of these pharmaceutical compositions can be formulated by combining with a pharmaceutically acceptable carrier.
Description
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more Application Information
Patent Timeline
Login to view more Owner JUNTENDO EDUCATIONAL FOUND
Who we serve
- R&D Engineer
- R&D Manager
- IP Professional
Why Eureka
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Social media
Try Eureka
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap